JP6626446B2 - 薬学的に適切な芳香族カチオン性ペプチド - Google Patents
薬学的に適切な芳香族カチオン性ペプチド Download PDFInfo
- Publication number
- JP6626446B2 JP6626446B2 JP2016542948A JP2016542948A JP6626446B2 JP 6626446 B2 JP6626446 B2 JP 6626446B2 JP 2016542948 A JP2016542948 A JP 2016542948A JP 2016542948 A JP2016542948 A JP 2016542948A JP 6626446 B2 JP6626446 B2 JP 6626446B2
- Authority
- JP
- Japan
- Prior art keywords
- acid
- hexafluorophosphate
- compound
- hydrogen
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1019—Tetrapeptides with the first amino acid being basic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/02—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361921376P | 2013-12-27 | 2013-12-27 | |
| US61/921,376 | 2013-12-27 | ||
| US201461947261P | 2014-03-03 | 2014-03-03 | |
| US61/947,261 | 2014-03-03 | ||
| PCT/US2014/072264 WO2015100376A1 (en) | 2013-12-27 | 2014-12-23 | Pharmaceutically relevant aromatic-cationic peptides |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017502956A JP2017502956A (ja) | 2017-01-26 |
| JP2017502956A5 JP2017502956A5 (https=) | 2018-02-08 |
| JP6626446B2 true JP6626446B2 (ja) | 2019-12-25 |
Family
ID=53479676
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016542948A Active JP6626446B2 (ja) | 2013-12-27 | 2014-12-23 | 薬学的に適切な芳香族カチオン性ペプチド |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US10221213B2 (https=) |
| EP (1) | EP3087093B1 (https=) |
| JP (1) | JP6626446B2 (https=) |
| CN (2) | CN112457368A (https=) |
| CA (1) | CA2935207C (https=) |
| WO (1) | WO2015100376A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6626446B2 (ja) * | 2013-12-27 | 2019-12-25 | ステルス バイオセラピューティックス コープ | 薬学的に適切な芳香族カチオン性ペプチド |
| EP3160984B1 (en) * | 2014-06-25 | 2021-04-14 | Flamma S.P.A. | Process for preparing d-arginyl-2,6-dimethyl-l-tyrosyl-l-lysyl-l-phenylalaninamide |
| WO2016001042A1 (en) * | 2014-06-30 | 2016-01-07 | Flamma S.P.A. | Process for the production of d-arginyl-2,6-dimethyl-l-tyrosyl-l-lysyl-l-phenylalaninamide |
| US10633415B2 (en) | 2015-03-06 | 2020-04-28 | Stealth Biotherapeutics Corp | Processes for preparing pharmaceutically relevant peptides |
| CA3020393A1 (en) | 2016-04-11 | 2017-10-19 | Carnot, Llc | Chiral peptides |
| CN110087667A (zh) * | 2016-08-16 | 2019-08-02 | 隐形生物治疗公司 | Elamipretide的基于N-羧基酸酐的规模合成 |
| CN110914287A (zh) | 2017-04-05 | 2020-03-24 | 隐形生物治疗公司 | Boc-d-arg-dmt-lys-(boc)-phe-nh2的结晶盐形式 |
| US20200361987A1 (en) * | 2017-11-15 | 2020-11-19 | Stealth Biotherapeutics Corp. | Deuterated tetrapeptides that target mitochondria |
| US10676506B2 (en) | 2018-01-26 | 2020-06-09 | Stealth Biotherapeutics Corp. | Crystalline bis- and tris-hydrochloride salt of elamipretide |
| CN108929371A (zh) * | 2018-08-02 | 2018-12-04 | 哈尔滨师范大学 | 一种Phakellistatin13直链衍生物、其制备办法及用途 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2067000C1 (ru) * | 1994-06-29 | 1996-09-27 | Владислав Исакович Дейгин | Пептид и способ его получения |
| US6248716B1 (en) * | 1995-06-27 | 2001-06-19 | Immunotech Developments Inc. | Peptide, a method for its preparation and a pharmaceutical composition containing the peptide |
| US20030069231A1 (en) * | 1999-10-12 | 2003-04-10 | Klaus Rudolf | Modified aminoacids, pharmaceuticals containing these compounds and method for their production |
| US7214663B2 (en) | 2000-06-14 | 2007-05-08 | Medarex, Inc. | Tripeptide prodrug compounds |
| US9278085B2 (en) | 2006-02-22 | 2016-03-08 | Edison Pharmaceuticals, Inc. | Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers |
| US20070213505A1 (en) * | 2006-03-08 | 2007-09-13 | David Epstein | Solution Synthesis of Peptide Cell Growth Stimulators |
| EP3375449A1 (en) | 2010-03-15 | 2018-09-19 | Stealth Peptides International, Inc. | Combination therapies using cyclosporine and aromatic cationic peptides |
| AU2012271691A1 (en) * | 2011-06-14 | 2014-01-16 | Stealth Peptides International, Inc. | Aromatic-cationic peptides and uses of same |
| HK1204988A1 (en) * | 2012-02-22 | 2015-12-11 | Stealth Peptides International, Inc. | Methods and compositions for preventing or treating ophthalmic conditions |
| EP2928562A4 (en) * | 2012-12-06 | 2016-06-22 | Stealth Peptides Int Inc | PEPTIDE THERAPEUTIC PRODUCTS AND METHODS OF USE |
| EP3060573B1 (en) | 2013-10-23 | 2019-07-17 | Kaneka Corporation | Tetrapeptide compound and method for producing same |
| JP6626446B2 (ja) * | 2013-12-27 | 2019-12-25 | ステルス バイオセラピューティックス コープ | 薬学的に適切な芳香族カチオン性ペプチド |
| HK1231493A1 (zh) * | 2014-03-03 | 2017-12-22 | Stealth Biotherapeutics Corp | 药学上相关的芳香族阳离子肽 |
-
2014
- 2014-12-23 JP JP2016542948A patent/JP6626446B2/ja active Active
- 2014-12-23 EP EP14874049.1A patent/EP3087093B1/en active Active
- 2014-12-23 US US15/108,004 patent/US10221213B2/en active Active
- 2014-12-23 CN CN202011243175.7A patent/CN112457368A/zh active Pending
- 2014-12-23 CA CA2935207A patent/CA2935207C/en active Active
- 2014-12-23 WO PCT/US2014/072264 patent/WO2015100376A1/en not_active Ceased
- 2014-12-23 CN CN201480075290.4A patent/CN106132984B/zh active Active
-
2019
- 2019-02-28 US US16/289,209 patent/US10696716B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2017502956A (ja) | 2017-01-26 |
| US20160340389A1 (en) | 2016-11-24 |
| CN112457368A (zh) | 2021-03-09 |
| EP3087093B1 (en) | 2021-11-10 |
| CN106132984B (zh) | 2020-12-08 |
| WO2015100376A1 (en) | 2015-07-02 |
| CA2935207A1 (en) | 2015-07-02 |
| EP3087093A1 (en) | 2016-11-02 |
| US10696716B2 (en) | 2020-06-30 |
| US20200024308A1 (en) | 2020-01-23 |
| CA2935207C (en) | 2022-06-21 |
| CN106132984A (zh) | 2016-11-16 |
| US10221213B2 (en) | 2019-03-05 |
| EP3087093A4 (en) | 2017-09-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6626446B2 (ja) | 薬学的に適切な芳香族カチオン性ペプチド | |
| JP7450572B2 (ja) | 薬学的に適切なペプチドを調製するための方法 | |
| JP2017512762A (ja) | 薬学的に妥当な芳香族カチオン性ペプチド及びその生成方法 | |
| CA2801101C (en) | Process for preparing a biphenyl-2-ylcarbamic acid | |
| HK40049251A (en) | Processes for preparing pharmaceutically relevant peptides | |
| HK1230631B (en) | Pharmaceutically relevant aromatic-cationic peptides | |
| CA2412787A1 (en) | Process for the preparation of 5-phenylpentanoyl-ala-argl-{2-[3-amino-2-oxopyrrolidin-1-yl]propionyl}-ala-arg-ala-4-aminophenylacetamide | |
| HK1248604A1 (en) | Processes for preparing pharmaceutically relevant peptides | |
| HK1248604B (en) | Processes for preparing pharmaceutically relevant peptides |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20171222 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20171222 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20181122 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20190220 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190521 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20191031 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20191129 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6626446 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |